The largest vaccine producer in the world has begun making 40 million coronavirus vaccines while it is still in the trial stages. The Serum Institute of India has started production before the University of Oxford completes the human trials. The Oxford Vaccine Group has commented that they hope to complete the tests by September. Last week the first two humans were injected with the vaccine out of about 1,100 who are set to participate. One million doses of the vaccine is the production goal set in place for September when the trials are complete. “The decision — at our own risk and cost — has been solely taken to get a jump-start on manufacturing, to have enough doses available, if the clinical trials prove successful,” commented CEO Adar Poonawalla.
The Crossroads of Special Operations